MY8700166A - Ergot alkaloids - Google Patents

Ergot alkaloids

Info

Publication number
MY8700166A
MY8700166A MY166/87A MY8700166A MY8700166A MY 8700166 A MY8700166 A MY 8700166A MY 166/87 A MY166/87 A MY 166/87A MY 8700166 A MY8700166 A MY 8700166A MY 8700166 A MY8700166 A MY 8700166A
Authority
MY
Malaysia
Prior art keywords
ergot alkaloids
ergot
alkaloids
Prior art date
Application number
MY166/87A
Inventor
Peter Gull
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY8700166A publication Critical patent/MY8700166A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
MY166/87A 1982-08-09 1987-12-30 Ergot alkaloids MY8700166A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (en) 1982-08-09 1982-08-09 ERGOL DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND HEALING AGENTS, CONTAINING THESE ERGOL DERIVATIVES AS AN ACTIVE SUBSTANCE.

Publications (1)

Publication Number Publication Date
MY8700166A true MY8700166A (en) 1987-12-31

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
MY166/87A MY8700166A (en) 1982-08-09 1987-12-30 Ergot alkaloids

Country Status (23)

Country Link
JP (1) JPS5948480A (en)
AT (1) AT383125B (en)
AU (1) AU563736B2 (en)
BE (1) BE897473A (en)
CA (1) CA1215972A (en)
CH (1) CH649998A5 (en)
DE (1) DE3327705A1 (en)
DK (1) DK361983A (en)
ES (1) ES524815A0 (en)
FI (1) FI73679C (en)
FR (1) FR2531433B1 (en)
GB (1) GB2125041B (en)
GR (1) GR78923B (en)
HU (1) HU187600B (en)
IL (1) IL69450A (en)
IT (1) IT1168961B (en)
MY (1) MY8700166A (en)
NL (1) NL8302776A (en)
NZ (1) NZ205181A (en)
PH (1) PH20385A (en)
PT (1) PT77168B (en)
SE (1) SE8304315L (en)
ZA (1) ZA835850B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (en) * 1985-11-13 1988-09-02 Roussel Uclaf USE OF ERGOLIN DERIVATIVES FOR OBTAINING A GERIATRIC MEDICINE
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (en) * 1989-04-21 1990-10-25 Schering Ag 8 (BETA) SUBSTITUTED ERGOLINE, METHOD FOR THE PRODUCTION AND USE THEREOF
DE10212564B4 (en) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
ES8502992A1 (en) 1985-02-01
DK361983A (en) 1984-02-10
DE3327705A1 (en) 1984-02-09
NZ205181A (en) 1986-07-11
ZA835850B (en) 1985-03-27
AT383125B (en) 1987-05-25
IL69450A0 (en) 1983-11-30
FI832789A (en) 1984-02-10
NL8302776A (en) 1984-03-01
IT1168961B (en) 1987-05-20
FR2531433B1 (en) 1985-10-18
BE897473A (en) 1984-02-06
CH649998A5 (en) 1985-06-28
FR2531433A1 (en) 1984-02-10
AU1767283A (en) 1984-02-16
ATA286383A (en) 1986-10-15
AU563736B2 (en) 1987-07-23
SE8304315L (en) 1984-02-10
JPS5948480A (en) 1984-03-19
IT8322490A0 (en) 1983-08-09
SE8304315D0 (en) 1983-08-08
GR78923B (en) 1984-10-02
PT77168A (en) 1983-09-01
FI73679B (en) 1987-07-31
IL69450A (en) 1986-10-31
GB2125041B (en) 1986-04-23
FI73679C (en) 1987-11-09
GB8321222D0 (en) 1983-09-07
HU187600B (en) 1986-01-28
ES524815A0 (en) 1985-02-01
GB2125041A (en) 1984-02-29
DK361983D0 (en) 1983-08-08
CA1215972A (en) 1986-12-30
FI832789A0 (en) 1983-08-02
PT77168B (en) 1986-03-27
PH20385A (en) 1986-12-08

Similar Documents

Publication Publication Date Title
GB8311973D0 (en) Quinoline derivatives
DE3377796D1 (en) Quinoline derivatives
GB8310843D0 (en) Ergoline derivatives
GB2125041B (en) Ergot alkaloids
AU553514B2 (en) Vinca alkaloids
GB8303475D0 (en) Ergot alkaloids
GB2093452B (en) Ergoline derivatives
PT72785B (en) Ergoline derivatives
GB2115811B (en) Ergot alkaloids
GB2092570B (en) Ergot alkaloids
ZA812103B (en) Ergoline derivatives
NZ189422A (en) Ergot peptide alkaloids
ZA83955B (en) Ergot alkaloids
GB2094798B (en) Ergot alkaloids
PH20160A (en) Ergoline derivatives
JPS57159783A (en) Manufacture of ergot alkaloids
GB2131674B (en) Ashtray
IE802091L (en) Ergot peptide alkaloids
GB2135307B (en) Ergot derivatives
KR840000329Y1 (en) Ashtray
KR860000957Y1 (en) Ashtray
ZA841150B (en) Ergot derivatives
GB8312447D0 (en) Ergot derivatives
KR830001175Y1 (en) Ash-tray
IE822659L (en) Morphinane derivatives